CB-5339 - Cleave Therap
Vyxeos (cytarabine/daunorubicin liposomal formulation) - Jazz
https://www.businesswire.com/news/home/20200909005183/en/Cleave-Therapeutics-Announces-Preclinical-Research-Collaboration-Jazz
 
Sep 9, 2020
 
Prev Next